Pharmacokinetic-pharmacodynamic modelling of the antinociceptive effect of a romifidine infusion in standing horses.

This study investigates the effect of the drug romifidine on pain and sedation in horses, and how this effect relates to the concentration of the drug in the horses’ blood.

Study Methodology

• The research is a prospective, experimental, nonrandomized trial, involving 10 healthy adult warmblood horses.
• The item being tested is romifidine, which was administered intravenously to the horses over a period of 120 minutes. Its dosage followed a protocol of a loading dose and continuous infusion.
• Various tests were conducted before, during, and after the romifidine administration. These included checks for sedation and antinociception (pain relief), and checking romifidine plasma concentrations through capillary electrophoresis.
• For measuring the nociceptive thresholds, an electrical stimulation was given at the horse’s thoracic limb, and any resultant nociceptive withdrawal reflex was recorded through electromyography at the deltoid muscle.

Results

• A two-compartment model best described the pharmacokinetic profile of romifidine, indicating that the drug distributes into two biological compartments.
• The drug was found to have a notable effect on increasing the antinociceptive (pain inhibition) thresholds in all the horses.
• While acknowledged as a sedative, the sedative effects of romifidine were more variable and not as easily correlated to plasma concentration or to its antinociceptive effect.
• The findings demonstrate that the antinociceptive effect had a delayed onset and lasted longer than the sedative effect when the administration of the drug was discontinued.

Conclusions

• The primary conclusion from the study is that romifidine has a significant antinociceptive (pain relieving) effect on horses, though this effect has a delay.
• Another key conclusion is that the sedative effect of the drug doesn’t last as long as the antinociceptive effect, even if it’s the most recognized effect of the drug. This could have important implications in veterinary treatment strategies using romifidine.